Your healthcare provider should do blood tests to check how well your liver is working before you begin treatment with IXEMPRA and as needed during treatment. If blood tests show that you have liver problems, do not receive injections of IXEMPRA along with capecitabine. If you have liver problems, taking these medicines together could increase your chance of serious infection and death due to a very low white blood cell count (neutropenia).
You should not have your injection of IXEMPRA if you are allergic to medicines that contain Cremophor® EL* (polyoxyethylated castor oil) or if you have a low white blood cell count or a low platelet count. Continue to full Important Safety Information below
IXEMPRA a prescription medicine, used to treat breast cancer when certain medicines have not worked or no longer work can be used alone or with capecitabine.
The Internet can be a great resource for finding information about metastatic breast cancer and for connecting with other women who understand what you are going through. But the number of Web sites on the Internet can be overwhelming. Listed below are some Web sites that can provide you with information and support.
American Cancer Society www.cancer.org 800-ACS-2345 (800-227-2345)
The Breast Cancer Fund www.breastcancerfund.org 866-760-8223
Breast Cancer Network of Strength www.networkofstrength.org
CancerCare, Inc. www.cancercare.org 800-813-HOPE (800-813-4673)
Metastatic Breast Cancer Network www.mbcnetwork.org 888-500-0370
National Breast Cancer Coalition www.natlbcc.org 800-622-2838
National Comprehensive Cancer Network www.nccn.com 215-690-0300
National Cancer Institute www.cancer.gov 800-4-CANCER (800-422-6237)
Bristol-Myers Squibb Company does not endorse and is not responsible for the content of any of the listed Web sites or the services provided by these organizations. This is not an exhaustive list of resources.
Please see the complete Important Safety Information, including boxed WARNING regarding liver disease.
IXEMPRA is a prescription medicine used to treat locally advanced or metastatic breast cancer following certain treatments. IXEMPRA can be used alone or with another cancer medicine called Xeloda® (capecitabine).
IXEMPRA is a trademark of Bristol-Myers Squibb Company. *Cremophor is a registered trademark of BASF AG. Xeloda is a registered trademark of Roche Laboratories. © 2010 Bristol-Myers Squibb, Princeton, New Jersey 08543 U.S.A. All rights reserved.
691US09WA1490110/10
A type of cancer treatment that uses certain medicines to destroy cancer cells. It can also harm healthy cells
A type of medicine that damages the DNA in cancer cells, causing them to die
Cancer that has spread from the breast to nearby tissue or lymph nodes
Small masses of tissue that are an important part of the immune system. The lymph nodes act as filters that trap harmful things in the body
Cancer that has spread from the breast to other parts of the body
When the insurance company decides if a treatment is medically necessary for the patient and will be paid for by the insurance company
A type of medicine that stops cancer cells from dividing